Effects of Vasodilators on Tumor Energy Metabolism
Author Information
Author(s): G.M. Tozer, R.J. Maxwell, J.R. Griffiths, P. Pham
Primary Institution: Medical Research Council Cyclotron Unit, Hammersmith Hospital
Hypothesis
How do hydralazine and prostacyclin affect the energy metabolism and pH of a transplanted rat fibrosarcoma?
Conclusion
Hydralazine is more effective than prostacyclin in increasing tumor inorganic phosphate levels and reducing tumor pH for the same initial fall in mean arterial blood pressure.
Supporting Evidence
- Hydralazine caused a significant increase in inorganic phosphate levels in tumors.
- Prostacyclin also increased inorganic phosphate but to a lesser extent than hydralazine.
- Both drugs significantly reduced tumor pH.
- Controlled bleeding did not change tumor inorganic phosphate levels.
Takeaway
The study looked at how two drugs, hydralazine and prostacyclin, change the energy levels in tumors. Hydralazine worked better at making the tumors use less energy.
Methodology
The study used 31P magnetic resonance spectroscopy to measure changes in tumor energy metabolism and pH after administering hydralazine and prostacyclin to rats.
Limitations
The effects of the drugs may not be directly applicable to clinical settings due to the severe hypotension required to observe significant changes.
Participant Demographics
8-12-week-old male BD9 rats
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website